CSIMarket Company Name, Ticker, Customers, else..


Eyepoint Pharmaceuticals Inc   (NASDAQ: EYPT)
Other Ticker:  
 

Eyepoint Pharmaceuticals Inc

EYPT's Fundamental analysis



Eyepoint Pharmaceuticals Inc 's sales fell by -17.39 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 939

Laboratory Analytical Instruments industry recorded growth of revenues by 1.41 %

Eyepoint Pharmaceuticals Inc net loss increased from $-14 millions, to $-41 millions in IV. Quarter 2024,

• More on EYPT's Growth


Eyepoint Pharmaceuticals Inc
realized a net loss in trailing twelve months.

Eyepoint Pharmaceuticals Inc realized cash reduction of $ -3.22 per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
9.46
PE TTM    
Company's Price to Sales ratio is at 8.3.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.9.


• More on EYPT's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 686,873
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 32.2
 Tangible Book Value (Per Share $) 5.97

Eyepoint Pharmaceuticals Inc
realized net loss in trailing twelve months.

Eyepoint Pharmaceuticals Inc realized cash outflow of $ -3.22per share in trailing twelve-month period.
Laboratory Analytical Instruments industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
9.46
PE TTM    
Company's Price to Sales ratio is at 8.3.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 3.9.

Eyepoint Pharmaceuticals Inc Price to Book Ratio is at 1.07 lower than Industry Avg. of 208.86. and higher than S&P 500 Avg. of 0.01

• More on EYPT's Valuation

•  Market Capitalization (Millions $) 359
•  Shares Outstanding (Millions) 56
•  Employees 63
•  Revenues (TTM) (Millions $) 43
•  Net Income (TTM) (Millions $) -131
•  Cash Flow (TTM) (Millions $) -182
•  Capital Exp. (TTM) (Millions $) -4
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 686,873
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 32.2
•  Tangible Book Value (Per Share $) 5.97

•  Market Capitalization (Millions $) 359
•  Shares Outstanding (Millions) 56
•  Employees 63
•  Revenues (TTM) (Millions $) 43
•  Net Income (TTM) (Millions $) -131
•  Cash Flow (TTM) (Millions $) -182
•  Capital Exp. (TTM) (Millions $) -4





  Ratio
•   Capital Ratio (MRQ) 7.81
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.18
•  Asset Turnover Ratio (TTM) 0.13
•  Inventory Turnover Ratio (TTM) 1.78





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com